UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts
Avatar

ASH Updates on cHL: 2L Pembro + GVD, Brentuximab Vedotin & Checkpoint Blockade Combination in High Risk Patients

By UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts FEATURING Peter Riedell
By UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts FEATURING Peter Riedell
121 views
March 5, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Recommended

10:52

Current Treatment of 1L Hodgkin Lymphoma

University of Miami Sylvester Comprehensive Cancer Center

C. Moskowitz

488 views
12:49

ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options in L…

2024 ASCO® Annual Meeting Insights Hub

P. Johnson

434 views
16:34

Top 5 Lymphoma Abstracts From ASH

Jennifer Amengual

615 views
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

904 views
21:56

Emerging and Current Treatment for Hodgkin Lymphoma in 2024

Indy Hematology Review

S. Ansell

387 views
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

304 views
26:43

Treatment Updates and Management of Hodgkin Lymphoma

Integrity CE

A. Niu, D. Wallace, M. Cortese

152 views
28:11

Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL…

Total Health

M. Rotta

240 views
20:49

Summary of Recent Updates in Advanced Hodgkin Lymphoma

SOHO Brazil 2024

C. Moskowitz

197 views
15:14

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

860 views
14:38

Top Risk Factors for Cancer by Sex and What to Do About It

MedCram

R. Seheult

156 views
14:47

EHA 2024 Insights: Treatment of Advanced Stage, High-Risk Hodgkin's …

Insights from 2024 EHA Annual Meeting

M. Salamoon

157 views
18:06

Summary of Recent Updates in R/R HL

SOHO Brazil 2024

C. Moskowitz

124 views
09:27

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

1.1K views
06:51

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

432 views
16:25

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

819 views
08:59

ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in Older …

Insights from 2023 ASH Annual Meeting

S. Rutherford

206 views
41:20

SOHO Highlights - State of the Art & Next Questions: Hodgkin Lymphoma

SOHO Highlights: State of the Art and Next Questions

N. Bartlett

349 views
15:56

2024 Updates in Management of Hodgkin Lymphoma

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

J. Svoboda

115 views
17:34

ASCO® 2024 Summary: "Treatment Considerations for Challenging Popula…

2024 ASCO® Annual Meeting Insights Hub

C. Burton

115 views
AUTOPLAY